BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 10954714)

  • 1. An oncogenic epidermal growth factor receptor signals via a p21-activated kinase-caldesmon-myosin phosphotyrosine complex.
    McManus MJ; Boerner JL; Danielsen AJ; Wang Z; Matsumura F; Maihle NJ
    J Biol Chem; 2000 Nov; 275(45):35328-34. PubMed ID: 10954714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grb2 regulation of the actin-based cytoskeleton is required for ligand-independent EGF receptor-mediated oncogenesis.
    Boerner JL; Danielsen AJ; Lovejoy CA; Wang Z; Juneja SC; Faupel-Badger JM; Darce JR; Maihle NJ
    Oncogene; 2003 Oct; 22(43):6679-89. PubMed ID: 14555981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transformation-associated complex involving tyrosine kinase signal adapter proteins and caldesmon links v-erbB signaling to actin stress fiber disassembly.
    McManus MJ; Lingle WL; Salisbury JL; Maihle NJ
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11351-6. PubMed ID: 9326613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
    Besset V; Scott RP; Ibáñez CF
    J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine phosphorylation of caldesmon is required for binding to the Shc.Grb2 complex.
    Wang Z; Danielsen AJ; Maihle NJ; McManus MJ
    J Biol Chem; 1999 Nov; 274(47):33807-13. PubMed ID: 10559276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
    Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts.
    Haugh JM; Huang AC; Wiley HS; Wells A; Lauffenburger DA
    J Biol Chem; 1999 Nov; 274(48):34350-60. PubMed ID: 10567412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.
    Piiper A; Elez R; You SJ; Kronenberger B; Loitsch S; Roche S; Zeuzem S
    J Biol Chem; 2003 Feb; 278(9):7065-72. PubMed ID: 12496267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the role of the Shc and Grb2 proteins in signal transduction by the v-ErbB protein.
    Meyer S; LaBudda K; McGlade J; Hayman MJ
    Mol Cell Biol; 1994 May; 14(5):3253-62. PubMed ID: 7909355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p21-activated kinase 1 (PAK1) interacts with the Grb2 adapter protein to couple to growth factor signaling.
    Puto LA; Pestonjamasp K; King CC; Bokoch GM
    J Biol Chem; 2003 Mar; 278(11):9388-93. PubMed ID: 12522133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
    Tauchi T; Boswell HS; Leibowitz D; Broxmeyer HE
    J Exp Med; 1994 Jan; 179(1):167-75. PubMed ID: 7505797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions.
    van der Geer P; Wiley S; Gish GD; Pawson T
    Curr Biol; 1996 Nov; 6(11):1435-44. PubMed ID: 8939605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells.
    Hennige AM; Lammers R; Arlt D; Höppner W; Strack V; Niederfellner G; Seif FJ; Häring HU; Kellerer M
    Mol Cell Endocrinol; 2000 Sep; 167(1-2):69-76. PubMed ID: 11000521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer.
    Dankort D; Maslikowski B; Warner N; Kanno N; Kim H; Wang Z; Moran MF; Oshima RG; Cardiff RD; Muller WJ
    Mol Cell Biol; 2001 Mar; 21(5):1540-51. PubMed ID: 11238891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation.
    Zeng L; Sachdev P; Yan L; Chan JL; Trenkle T; McClelland M; Welsh J; Wang LH
    Mol Cell Biol; 2000 Dec; 20(24):9212-24. PubMed ID: 11094073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells.
    Piccinini G; Bacchiocchi R; Serresi M; Vivani C; Rossetti S; Gennaretti C; Carbonari D; Fazioli F
    J Biol Chem; 2002 Jun; 277(25):22231-9. PubMed ID: 11919185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-independent oncogenic transformation by the EGF receptor requires kinase domain catalytic activity.
    Danielsen AJ; Maihle NJ
    Exp Cell Res; 2002 Apr; 275(1):9-16. PubMed ID: 11925101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine-phosphorylated low density lipoprotein receptor-related protein 1 (Lrp1) associates with the adaptor protein SHC in SRC-transformed cells.
    Barnes H; Larsen B; Tyers M; van Der Geer P
    J Biol Chem; 2001 Jun; 276(22):19119-25. PubMed ID: 11259429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
    Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
    Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites.
    Fan YX; Wong L; Deb TB; Johnson GR
    J Biol Chem; 2004 Sep; 279(37):38143-50. PubMed ID: 15231819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.